Back to search

Article

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies

2022-12-31

Abstract excerpt

Sickle cell disease (SCD) is due to a mutation in the β-globin ( HBB ) gene causing the production of the toxic sickle hemoglobin (HbS, a 2 β S 2 ). Transplantation of autologous hematopoietic stem/progenitor cells (HSPCs) transduced with lentiviral vectors (LVs) expressing an anti-sickling β-globin (βAS) is a promising treatment; however, it is only partially effective and patients still present elevated HbS l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
33272160-ae97-5036-8260-9d65b7115e0f
DOI
10.1101/2022.12.31.522279
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategiesDOI 10.1101/2022.12.31.522279
Select a neighboring publication to make it the new centre.